{"id":"NCT03660943","sponsor":"Centrexion Therapeutics","briefTitle":"A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain","officialTitle":"A Randomized, Double-blind, Placebo-controlled, 2-Injection, 52-Week Study to Evaluate the Efficacy and Safety of Intra-articular Injections of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-09-09","primaryCompletion":"2020-06-11","completion":"2020-06-11","firstPosted":"2018-09-07","resultsPosted":"2022-07-21","lastUpdate":"2022-07-21"},"enrollment":332,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"CNTX-4975-05","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"CNTX-4975-05","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.","primaryOutcome":{"measure":"Mean Change From Baseline in WOMAC A (Pain) Dimension","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo","deltaMin":-14.13,"sd":12.217},{"arm":"CNTX-4975-05","deltaMin":-17.16,"sd":12.266}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0833"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":140},"commonTop":["Viral upper respiratory tract infection","Arthralgia","Upper respiratory tract infection","Bronchitis","Sinusitis"]}}